Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

A cellular housekeeping process where cells break down and recycle damaged components. Declines with age and is stimulated by fasting.

What is Intermittent fasting?

An eating pattern that cycles between periods of fasting and eating. Various protocols (16:8, 5:2) are studied for metabolic, cardiovascular, and longevity benefits.

What is Zone 2 cardio?

Low-intensity aerobic exercise performed at roughly 60–70% of maximum heart rate, primarily using the aerobic energy system. Associated with mitochondrial health and longevity.

Geographic regions identified by researchers where people consistently live longer and healthier lives than average, including Sardinia, Okinawa, and Loma Linda.

Monthly Report: May 2026 | HealthspanWire

The month of May 2026 brought a mix of breakthroughs and setbacks in the field of longevity science, with a particular focus on Alzheimer’s disease. Alector’s decision to halt the Phase 2 trial of Nivisnebart for early Alzheimer’s patients was a significant development, highlighting the challenges in treating this complex condition. Meanwhile, promising new treatments for Alzheimer’s symptoms and other age-related diseases are emerging, offering hope for improved quality of life as we age.

What the science showed this month

Alzheimer’s Disease: A Mixed Bag

This month, the field of Alzheimer’s research saw both setbacks and advancements. Alector discontinued its Phase 2 trial for Nivisnebart, a drug aimed at treating early Alzheimer’s, due to disappointing results Alector discontinues Phase 2 trial of Nivisnebart in early Alzheimer’s disease. On the brighter side, the FDA approved AUVELITY, a new medication designed to treat agitation in Alzheimer’s patients, providing a new option for managing symptoms New Alzheimer’s Drug May Ease Agitation Symptoms.

Breast Cancer Treatment Advances

In cancer treatment, the FDA approved VEPPANU (vepdegestrant), the first PROTAC therapy for advanced breast cancer, offering new hope for patients with this challenging condition New Drug Offers Hope for Advanced Breast Cancer Patients. This approval marks a significant step forward in targeted cancer therapies.

Gut Health and Liver Cancer

Research continues to highlight the importance of gut health in preventing age-related diseases. A study showed that fecal microbiota transplantation (FMT) from young to older mice reduced liver cancer risk, emphasizing the potential of gut microbiome interventions in longevity Can gut health reduce your risk of liver cancer?.

Food, movement, and daily habits

The Role of Meal Timing

Emerging research suggests that when you eat may be as important as what you eat for healthy aging. Studies are exploring how meal timing can influence cellular rejuvenation and prevent age-related diseases Can meal timing affect how you age?. This aligns with the growing interest in intermittent fasting and time-restricted eating as strategies to enhance longevity.

Exercise and Muscle Health

A new study from Edith Cowan University revealed that slow, controlled movements, known as eccentric exercises, can effectively build muscle without intense workouts Build Muscle with Less Effort: Try Eccentric Exercises. This finding is particularly relevant for older adults looking to maintain muscle mass and strength with less strain on their bodies.

Late-Night Eating and Gut Health

Research involving over 11,000 participants found that late-night eating, combined with stress, can harm gut health, highlighting the importance of mindful eating habits Can late-night snacks harm your gut health?. Maintaining a regular eating schedule and managing stress are crucial for preserving gut microbiome health.

What might change how we age

The most significant development this month is the FDA’s approval of AUVELITY, a new treatment for agitation in Alzheimer’s patients, marking a crucial step in managing symptoms of this challenging disease.

In addition to AUVELITY, a new DNA-based therapy targeting cholesterol levels without the side effects of statins is gaining attention Could a new DNA therapy replace statins for cholesterol?. As these therapies progress through trials, they could offer new options for managing chronic conditions and improving quality of life.

What this means for you

This month’s findings underscore the complexity of treating age-related diseases like Alzheimer’s and the importance of lifestyle factors in promoting longevity. While new drugs and therapies are on the horizon, maintaining a healthy lifestyle through mindful eating, regular exercise, and stress management remains essential. As research continues to evolve, staying informed about new treatments and their potential impact on your health can empower you to make proactive choices in your wellness journey.

Who is building what

The longevity field continues to attract significant investment and innovation. Companies like Arvinas and Axsome Therapeutics are leading the way with new drug approvals, while partnerships between firms like Chrysea Labs and NubioAge are expanding access to compounds like spermidine, known for its potential in healthy aging Could spermidine help you age better with doctor support?. These developments highlight the growing interest in and commitment to advancing longevity science.

What to watch next month

Clinical Trial Results: Keep an eye on the upcoming results from the ACACIA-HCM study, which could offer new insights into heart health What new heart treatment could mean for you.
Gut Health Research: Further studies on the impact of meal timing and gut health interventions are expected, potentially offering new strategies for aging well.
Alzheimer’s Treatments: As new Alzheimer’s drugs continue to progress, watch for updates on their efficacy and safety in managing symptoms.
DNA Therapy Developments: Stay tuned for advancements in DNA-based therapies, which hold promise for treating chronic conditions without traditional side effects.

Signal Tracker Updates

Multi-omic blood panels are enabling personalized aging assessments (blood-biomarker-panels): 4 linked post(s) (supports: 0, contradicts: 0, mixed: 4, mentions: 0).
Epigenetic clocks are becoming standard biological age measures (epigenetic-clock-adoption): 9 linked post(s) (supports: 0, contradicts: 0, mixed: 9, mentions: 0).
Gene therapies targeting aging pathways are entering clinical development (gene-therapy-aging): 1 linked post(s) (supports: 0, contradicts: 0, mixed: 1, mentions: 0).
Microbiome composition is linked to aging trajectories (gut-microbiome-aging): 10 linked post(s) (supports: 0, contradicts: 0, mixed: 10, mentions: 0).
Senolytic therapies are showing clinical efficacy in human trials (senolytic-clinical-validation): 11 linked post(s) (supports: 0, contradicts: 0, mixed: 11, mentions: 0).